Lupin Limited has informed the Exchange regarding a press release dated August 05, 2020, titled "Lupin Launches Favipiravir Drug Covihalt�� for Treatment of Mild to Moderate COVID-19".
Lupin Limited has informed the Exchange regarding a press release dated August 05, 2020, titled "Lupin Launches Favipiravir Drug Covihalt�� for Treatment of Mild to Moderate COVID-19".